chrisvoncsefalvay/vaers-outcomes huggingface dataset:
a bit of warmth at site; Initial information received on 30-Jan-2021 regarding an unsolicited valid non-serious case received from a consumer or non-health care professional via social media.  This case involves a patient of unknown age and gender who experienced bit of warmth at site (vaccination site warmth), while he/she received vaccine INFLUENZA VACCINE.  It was reported that it was shot doing it was worked so no pain. Just tough it out . It beats hell. Alternative: would probably ask about Pneumonia shot too.  The patient's vaccination(s) included COVID-19 VACCINE and had side effects from it (felt like crap & got bumps in armpit). The patient's past medical history, concomitant therapy, medical treatment(s) and family history were not provided. At the time of the event, the patient had COVID-19 (Coronavirus disease) (he was recovering from COVID).  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiry date not reported) via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed non-serious a bit of warmth at site (vaccination site warmth) (Unknown latency) following the administration of INFLUENZA VACCINE.  Patient stated that "he/she was stupid for decades because his folks got sick when they got shots. So he/she just got Flu & almost died twice. He/She got Flu shot between COVID shots. Did not feel Flu shot. It sucked his/her strength like a Vampire. Patient also mentioned "It was up to individuals to decide if they can Live with Guilt if they do not get shots & give these sickness to somebody who never recovers.  Details of laboratory data were not reported.  It was not reported if the patient received any corrective treatment.  At the time of reporting, outcome of the event was unknown.  There will be no information available on batch number for this case.
Patient II, a 45-year-old female with a history of vaccine-related anxiety, presented to the vaccine clinic for her second-dose of the pfizer COVID-19  vaccine.  Pharmacist then delivered vaccine. Almost immediately after administration, the patient started showing signs of distress including difficulty speaking, and going in an out of consciousness. Ice packs were placed on the back of patient's neck, and she was given water in order to hopes to stimulate  consciousness. At this time, the pharmacist placed a pulse oximeter on her finger to monitor.  Her oxygen stats dropped  to 75%  and heart rate dropped to a value slightly greater to slightly under 30 beats per minute as indicated by the pulse ox blinking at 30.  Pharmacist timed the period of bradycardia, after 60 seconds an epinephrine pen 0.3mg was administered to the left lateral thigh. Rapid response code was called and team came 1.5 - 2 minutes after epinephrine administration. Oxygen was given to the patient at the scene where her recorded blood pressure was 94/54 mmHg. She was then transported into the emergency department via wheelchair. Patient stabilized and was discharged back to work approximately an hour after arrival.
cannot walk without a severe limb; still has pain in the left hip and cant walk without a limp or cane; pain in both knees especially the left knee and both sides of hip; This spontaneous case was reported by a consumer and describes the occurrence of GAIT DISTURBANCE (cannot walk without a severe limb), WALKING AID USER (still has pain in the left hip and cant walk without a limp or cane) and ARTHRALGIA (pain in both knees especially the left knee and both sides of hip) in an 88-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031M20A or 038K20A and 031M20A or 038K20A) for COVID-19 vaccination.     The patient's past medical history included Arthritis, Diabetes and Surgery. Concurrent medical conditions included Limping.   On 02-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced GAIT DISTURBANCE (cannot walk without a severe limb), WALKING AID USER (still has pain in the left hip and cant walk without a limp or cane) and ARTHRALGIA (pain in both knees especially the left knee and both sides of hip). On 12-Mar-2021, ARTHRALGIA (pain in both knees especially the left knee and both sides of hip) had not resolved. At the time of the report, GAIT DISTURBANCE (cannot walk without a severe limb) and WALKING AID USER (still has pain in the left hip and cant walk without a limp or cane) outcome was unknown.            No Concomitant medications were provided Reporter provided two lot numbers but was not sure which one is for dose one and dose two. Lot#:031M20A or 038K20A No Treatment information provided
Burning pain in deltoid and trapezius muscle, limited range of motion in neck, inflammation and pain at the site of administration 10 weeks post shot.
1 week exactly after receiving the COVID-19 vaccine I woke up with a swollen and itchy arm. The rash and swelling measures approx 6 inches  and has not been alleviated  by hydrocortisone or ibuprofen.   Previous to this my only symptoms were a headache for 2 days and some arm soreness.
ANGINA, UNSPECIFIED 11/20/2022,  3/3/2023,  2/9/2023  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Before the vaccine, I already had a mild case of tinnitus that would come and go.  Over the last few months, it is present almost constantly and it is much louder
on 2/14 he woke up and couldn't move his left side, couldn't walk.  Went to ER, numerous tests were run and there was nothing to substantiate.  ER suggested to follow up with neurologist, neurologist said possibly Parkinson's.  Went to more dr's, they don't think Parkinson's.  Started getting better a few days before the second dose, got the second dose on 2/25. After the second things everything was exscaberated, weight started dropping, started losing muscle tone, appetite, and extreme fatigue.  Cognitive thinking was gone,almost like a psychosis, was suicidal, couldn't think straight.  Went back to the Er, couldn't find anything.  They admitted him to observe and could find nothing.  We came home and continually
Client reported acute, sharp chest pain the moment the needle entered his arm. Chest pain was temporarily relieved by pressure, accompanied by diaphoresis, tachypnea and hypertension. EMS was called and initial EKG showed abnormal T waves. Client was transported to hospital for further care.
Didn?t feel good then Cardiac arrest cpr given on arrest  had inflammation of heart. Given Corey and Amiodarone . Treatment ongoing
Muscle pain; Joint pain; Chills; Nausea; This is a spontaneous report from a contactable consumer, the patient. A 47-year-old non-pregnant female patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 06Apr2021 at 15:00 (at the age of 47-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient was not allergic to medications, food, or other products. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 06Apr2021 at 22:30, the patient experienced muscle pain, joint pain, chills and nausea. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of the events muscle pain and joint pain which included treatment with pain relief (unspecified). The clinical outcome of the events muscle pain, joint pain, chills and nausea were resolved on an unknown date in Apr2021 at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
48 hours after multiple lumps; Lumps on collarbone, armpit 7pm; Lumps on collarbone, armpit 7pm; Weird chemical taste in mouth; Fever chills; So thirsty; Radiating pain left side; Heart palps; Back pain; Swelling; Left upper side of body stilltender/sore; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old, non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FA7485) via an unspecified route of administration in the left arm on 02Aug2021 at 12:00 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. Medical history included mitral valve regurgitation and blood pressure high (reported healthy otherwise). The patient was allergic to PHENERGAN. Prior to the vaccination ,it was unknown if the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any medication within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 03Aug2021 at 01:30, 14 hours after shot the patient had fever chills, thirsty, radiating pain left side, heart palpitations and back pain. On 03Aug2021 at 19:00, approximately 30 hours after shot the patient had lumps on collarbone, armpit and had weird chemical taste in mouth. On 4Aug2021, 48 hours after  multiple lumps felt swelling. On an unknown date in Aug2021, one week after shot the patient had collarbone swelling and left upper side of body was tender/sore. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events fever chills, so thirsty, radiating pain left side, heart palpitations, back pain, lumps on collarbone, armpit, weird chemical taste in mouth, multiple lumps felt, swelling and left upper side of body still tender/sore were not recovered at the time of this report
J96.00 ACUTE RESPIRATORY FAILURE 7/1/2021 SHORTNESS OF BREATH R09.02 HYPOXIA 7/1/2021 SHORTNESS OF BREATH
On February 11, 2021 around 10:15 am, patient was given the Moderna brand COVID-19 vaccination. After his vaccination, he was instructed to wait around for 15 minutes after the administration of the vaccine. During this time, there were no reported issues with the patient. On February 15, 2021 around 9:15am, patient's wife called the pharmacy and spoke with the pharmacist informing her that patient had passed away in his sleep on Saturday evening. Patient's wife inquired about whether death may have been caused by an adverse reaction to the vaccine. During the call patient's wife mentioned that patient slept a lot the day of the vaccine and the day after. patient's wife mentioned that patient woke up Saturday to eat breakfast and lunch. She states that later that evening, she found patient asleep and cold which she then realized that he'd passed away.
Redness at the injection site; Induration at the injection site; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE ERYTHEMA (Redness at the injection site) and VACCINATION SITE INDURATION (Induration at the injection site) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE ERYTHEMA (Redness at the injection site) and VACCINATION SITE INDURATION (Induration at the injection site). At the time of the report, VACCINATION SITE ERYTHEMA (Redness at the injection site) and VACCINATION SITE INDURATION (Induration at the injection site) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter. No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 18-Feb-2021: Outcome of events updated.
Headache, soreness at injection site, fatigue Narrative: Had 2nd dose yesterday, and arm was twice as sore as the first time. Today, headache x 3 hrs, feeling of fatigue. Denies fever although felt chilled temporarily last night.
Right arm red and swollen. Patient unable to move arm, fever began on 12/2/13. Was given an injection of Lincomycin and started on clindamycin and patient is to return if not better.
pt brought to hospital with poor oral intake, visual hallucinations, and agitation; recently tested positive for COVID; DNR/DNI; dexamethasone and remdesivir given; pt's condition did not improve and per death certificate he died in the hospital with causes of death being:  AHRF, encephalopathy, and COVID
This spontaneous report as received from a physician via a company representative refers to a 1 years old male patient. On 12-OCT-2012 the patient was vaccinated with 0.5 ml M-M-R II (lot # reported as 1644Z, expiration date unspecified). Concomitant medications included PREVNAR, HIB and a flu vaccine (manufacturer's unspecified). On 12-OCT-2012 the patient "had full body rashes, but no itching". It was unspecified if the patient sought for medical attention. On an unspecified date the patient recovered. This is one of several reports received from the same source. Additional information is not expected.
first dose-stabbing pains in joints, fever, tired=4 days second dose=42 hours later-throwing up, diarrhea, aches, sore throat, congestion, lost sense of smell & taste, tiredness, weight loss.  effects have laster 8.  days so far.
pain near where both of his kidneys are located; strong chills; At night when he is laying in bed, he cannot feel his feet. His feet are freezing and he cannot get them warm at all; Had a hard time sleeping. Only had an hour of sleeping; At night he has been really cold; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 74-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), dose 1 via an unspecified route of administration, administered in Arm Left on 16Feb2021 13:00 (Batch/Lot Number: EL9264) as DOSE 1, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. Prior to vaccination within 4 weeks the patient received Shingles shot. Patient reported he received first dose of vaccine on 16Feb. He had strong chills (on 17Feb2021) and pain near where both of his kidneys are located. Patient would like to know if this side effect was normal if it had been reported and when will symptoms go away. Felt like someone hit him in the kidneys. There was pain back there. At night when he was laying in bed, he could not feel his feet. His feet were freezing, and he could not get them warm at all. Real strong chills: Began the next day. Had a little bit of chill right now. Had gotten better as he moved around. Had a hard time sleeping. Only had an hour of sleeping. Pain in kidney area (on 19Feb2021): pain was on both sides. Feet Freezing and cannot get warm: Same time as chills. It was the first thing he noticed. The patient underwent lab tests and procedures which included computerised tomogram: unknown results on 17Feb2021 Day following the COVID-19 Vaccine had a CT scan. Was told the CT scan wouldn't matter with receiving the COVID-19 Vaccine. The clinical outcome of the event Chills was not recovered and remaining all other events was unknown at the time of report.  No follow-up attempts are possible. No further information is expected.
This spontaneous report was received from a nurse concerning multiple unspecified patients (demographics unknown). The patients' pertinent medical history and concurrent conditions were not provided. On unspecified dates, the patients were administered doses of improperly stored ROTATEQ (Lot # L013204; expiration date: 28-JAN-2017) and (Lot # L027070; expiration date: 30-APR-2017) (dose not provided). Concomitant therapies were not provided. No adverse effect was reported. It was reported the following temperature excursion for the administered vaccines: high temperature: 49.1 F for 1 hour 48 minutes and low temperature: 33.0 F for 35.9 hours. No previous temperature excursion was reported. This is one of several reports received from the same source. Additional information has been requested.
No adverse event; Dose administered after 30-day Use by Date to 7 patients; This spontaneous case was reported by a consumer and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use by Date to 7 patients) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 045H22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 23-Mar-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .5 milliliter. On 23-Mar-2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use by Date to 7 patients). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use by Date to 7 patients) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use by Date to 7 patients).    No concomitant medication details was reported. No treatment medication details was reported.  This case contains information for the 3rd patient out of 7 adult patients described by the reporter.   This case was linked to US-MODERNATX, INC.-MOD-2023-721391 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-721391:Patient 1 out of 7 patients
Pediatric dose administered to an adult; Pediatric dose administered to an adult; This case was reported by a pharmacist via call center representative and described the occurrence of underdose in a 50-year-old female patient who received HBV (Engerix B pediatric) (batch number yy203, expiry date 4th April 2024) for prophylaxis.   Co-suspect products included hepatitis B vaccine pre-filled syringe device (Engerix B Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 17th January 2023, the patient received Engerix B pediatric 10 µg and Engerix B Pre-Filled Syringe Device. On 17th January 2023, unknown after receiving Engerix B pediatric and Engerix B Pre-Filled Syringe Device, the patient experienced underdose and adult use of a child product. On an unknown date, the outcome of the underdose and adult use of a child product were unknown.     This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK receipt date: 19-Jan-2023 Reporter's comment: The vaccine administration facility was the same as primary reporter. The reporter did not consent to follow-up. Additional supportive information: An adult patient was administered a pediatric dose of Engerix-B, which led to underdose and adult use of a child product.
Painful cellulitis. Treated by Dicloxacillin 500mg 4 times a day for 7 days.
Fever @ 100.7; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever @ 100.7) in a 79-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013J201A) for COVID-19 vaccination.     The patient's past medical history included Erdheim-Chester disease (Treated with Tafinlar 200mg a day.) and UTI. Concomitant products included DABRAFENIB MESILATE (TAFINLAR), APIXABAN (ELIQUIS), ASPIRIN [ACETYLSALICYLIC ACID], ROSUVASTATIN CALCIUM (CRESTOR), MANNOSE, D- and PREDNISONE for an unknown indication.    On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jan-2021, the patient experienced PYREXIA (Fever @ 100.7). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 500 milligram. At the time of the report, PYREXIA (Fever @ 100.7) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 100.7 (High) 100.7.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter stated the patient normally runs a fever due to an UTI  but was aware that it was not the case in this matter.   This case was linked to MOD-2021-074374 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 20-May-2021: Reporter contact information, event outcome updated.
9/28/17 Low grade fever, 9/29/17 vomiting, 9/30/17 dysuria, 10/3/17 seizure, 10/9/17 seizure, 10/12/17 seizure.
Patient should have received a Tdap patient was administered a DTaP. No adverse event reported. Patient notified of mistake. There was not an adverse event this was a misadministration error on 5/11/09 where an adult received a childs dose of DTAP instead of an adult dose of TDAP.
Patient arrived for 2nd dose of COVID-19 vaccine. She was given Moderna instead of Pfizer
Fever; Chills; Myalgia; Headache; Feeling weak; anorexia; This is a spontaneous report from a contactable consumer.  A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot number: EH9899), via an unspecified route of administration on 22Dec2020 at a single dose for COVID-19 immunization.  The patient's medical history and concomitant medications were not reported.  The patient experienced fever, myalgia, feeling weak, anorexia and headache in Dec2020.  The patient reported that the symptoms lasted over 48 hours.  The outcome of the events was unknown.
3/29/23 I noticed difficulty swallowing and a pain in my neck and throat. I was seen yesterday in the Emergency Room because I am having more trouble swallowing. I have pain in neck and tightness in my throat.  I had an ultra sound  on 4/4/23 and nodules on my thyroid were found. I have a follow up, uncertain of date.
Patient reported body aches for 3 days. There was a bump and itchiness at first also. Patient just overall was not feeling well post-vaccine...primarily with the overall body aching.